Fig. 2: Symptoms at baseline.

Patient-reported prevalence (A), physician-assessed prevalence (B), and mean patient-reported symptom severity (C) at baseline are shown. Prevalence was defined as a symptom score greater than or equal to 1 (patient) or “yes” (physician). ET essential thrombocythemia, PV polycythaemia vera, PMF primary myelofibrosis, other other/unclassified MPN.